Candesartan ameliorates brain inflammation associated with Alzheimer's disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Candesartan ameliorates brain inflammation associated with Alzheimer's disease
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 24, Issue 3, Pages 231-242
Publisher
Wiley
Online
2018-01-25
DOI
10.1111/cns.12802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beneficial effects of Angiotensin II receptor blockers in brain disorders
- (2017) J.M. Saavedra PHARMACOLOGICAL RESEARCH
- Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
- (2017) Jose L. Labandeira-Garcia et al. Frontiers in Aging Neuroscience
- Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization
- (2017) Wei Zhao et al. JOURNAL OF ALZHEIMERS DISEASE
- Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging
- (2016) Lorraine Hamelin et al. BRAIN
- Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice
- (2016) Sabine Hellwig et al. BRAIN BEHAVIOR AND IMMUNITY
- Microglia in Alzheimer’s disease: A multifaceted relationship
- (2016) Ayman ElAli et al. BRAIN BEHAVIOR AND IMMUNITY
- Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer’s Disease
- (2016) Juan M. Saavedra CELLULAR AND MOLECULAR NEUROBIOLOGY
- Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
- (2016) Dario Tejera et al. Current Alzheimer Research
- An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease
- (2016) Abdel G. Elkahloun et al. Alzheimers Research & Therapy
- Mechanisms of Aβ Clearance and Degradation by Glial Cells
- (2016) Miriam Ries et al. Frontiers in Aging Neuroscience
- Intranasal Drug Delivery: How, Why and What for?
- (2016) Anaísa Pires et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies
- (2016) Nofar Torika et al. PLoS One
- Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKKβ-dependent AMPK activation
- (2015) Yuan Xu et al. BRAIN BEHAVIOR AND IMMUNITY
- Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation
- (2015) Tarja Malm et al. Journal of Neuroinflammation
- Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition
- (2015) Shahnawaz Ali Bhat et al. MOLECULAR NEUROBIOLOGY
- Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
- (2015) Carlo Condello et al. Nature Communications
- Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model
- (2014) Brice Ongali et al. NEUROBIOLOGY OF DISEASE
- Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice
- (2013) Sekar Sathiya et al. NEUROPHARMACOLOGY
- Microglia and Inflammation in Alzheimers Disease
- (2012) Shweta Mandrekar-Colucci et al. CNS & Neurological Disorders-Drug Targets
- Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
- (2012) Pablo Garrido-Gil et al. Journal of Neuroinflammation
- PPAR /RXR -Induced and CD36-Mediated Microglial Amyloid- Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
- (2012) M. Yamanaka et al. JOURNAL OF NEUROSCIENCE
- Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques
- (2012) Akihiro Noda et al. NUCLEAR MEDICINE AND BIOLOGY
- The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases
- (2012) John W. Wright et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Angiotensin II AT1 Receptor Blockers Ameliorate Inflammatory Stress: A Beneficial Effect for the Treatment of Brain Disorders
- (2011) Juan M. Saavedra CELLULAR AND MOLECULAR NEUROBIOLOGY
- Telmisartan Improves Insulin Resistance and Modulates Adipose Tissue Macrophage Polarization in High-Fat-Fed Mice
- (2011) Shiho Fujisaka et al. ENDOCRINOLOGY
- Brain renin-angiotensin—A new look at an old system
- (2011) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Angiotensin II sustains brain inflammation in mice via TGF-β
- (2010) Tobias V. Lanz et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
- (2010) Julius Benicky et al. NEUROPSYCHOPHARMACOLOGY
- Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications
- (2010) Juan M. Saavedra et al. PSYCHONEUROENDOCRINOLOGY
- Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
- (2010) Lusine Danielyan et al. REJUVENATION RESEARCH
- Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
- (2009) Julius Benicky et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Microglia Mediate the Clearance of Soluble A through Fluid Phase Macropinocytosis
- (2009) S. Mandrekar et al. JOURNAL OF NEUROSCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now